| # | Drug | Count |
|---|---|---|
| 0 | PREDNISONE | 302 |
| 1 | METHOTREXATE SODIUM | 288 |
| 2 | METHOTREXATE | 264 |
| 3 | METHYLPREDNISOLONE | 219 |
| 4 | ETOPOSIDE | 184 |
| 5 | PEGASPARGASE | 180 |
| 6 | CYTARABINE | 179 |
| 7 | FILGRASTIM | 168 |
| 8 | MERCAPTOPURINE | 168 |
| 9 | PREDNISOLONE | 166 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DAUNORUBICIN HYDROCHLORIDE | 50 | 0.0303 |
| 1 | PEGASPARGASE | 180 | 0.0145 |
| 2 | MERCAPTOPURINE | 168 | 0.0096 |
| 3 | HYDROCORTISONE SODIUM SUCCINATE | 35 | 0.0088 |
| 4 | TEDIZOLID PHOSPHATE | 7 | 0.0087 |
| 5 | CEFOXITIN SODIUM | 12 | 0.0086 |
| 6 | DEXRAZOXANE FOR INJECTION | 7 | 0.0074 |
| 7 | MESNA INJECTION | 55 | 0.0066 |
| 8 | CALCIUM FOLINATE | 31 | 0.0065 |
| 9 | LIDOCAINE HCL 3% | 3 | 0.0065 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 559 |
| 1 | Folate Analog Metabolic Inhibitor [EPC] | 264 |
| 2 | Topoisomerase Inhibitor [EPC] | 184 |
| 3 | Asparagine-specific Enzyme [EPC] | 180 |
| 4 | Nucleoside Metabolic Inhibitor [EPC] | 180 |
| 5 | Leukocyte Growth Factor [EPC] | 169 |
| 6 | Alkylating Drug [EPC] | 133 |
| 7 | Macrolide Antimicrobial [EPC] | 91 |
| 8 | Calcineurin Inhibitor Immunosuppressant [EPC] | 83 |
| 9 | Tumor Necrosis Factor Blocker [EPC] | 64 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Asparagine-specific Enzyme [EPC] | 180 | 0.0134 |
| 1 | Polyene Antimicrobial [EPC] | 2 | 0.0049 |
| 2 | Tetracycline-class Antibacterial [EPC] | 35 | 0.0045 |
| 3 | CD19-directed Cytolytic Antibody [EPC] | 3 | 0.0035 |
| 4 | Topoisomerase Inhibitor [EPC] | 184 | 0.0024 |
| 5 | Rifamycin Antimycobacterial [EPC] | 8 | 0.0023 |
| 6 | Macrolide Antimicrobial [EPC] | 91 | 0.0017 |
| 7 | Oxazolidinone Antibacterial [EPC] | 50 | 0.0017 |
| 8 | Aminoglycoside Antibacterial [EPC] | 58 | 0.0013 |
| 9 | Leukocyte Growth Factor [EPC] | 169 | 0.0012 |